Theranostics
The FDA-approved immune checkpoint inhibitors include ipilimumab [34], pembrolizumab [35], nivolumab [36], atezolizumab [37], avelumab [38], durvalumab [39] and cemiplimab [40]. The ACT therapy utilizes the cytotoxic capabilities of T lymphocytes to kill cancer cells, including tumor-infiltrating lymphocyte (TIL) therapy [41, 42], T cell ... ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.